In June 2011, several federal agencies issued policy guidance documents regarding the regulation of nanomaterials. Although the guidance documents were issued by several different agencies, including the Office of Management and Budget, the Food and Drug Administration (FDA), and the Environmental Protection Agency (EPA), they all convey the need to strike a careful balance between protecting human health, welfare, and the environment while fostering regulatory certainty for businesses on the forefront of innovation of nanomaterials and nanotechnology. The guidance documents issued by FDA and EPA were published in draft form, and public comments must be submitted by August 15, 2011, and July 18, 2011, respectively.
- How-to guide How-to guide: What general counsel (GC) need to know about environmental, social and governance (ESG) Recently updated
- How-to guide How-to guide: Understanding environmental, social and governance (ESG) Recently updated
- How-to guide How-to guide: How to understand and implement the ‘E’ in environmental, social and governance (ESG) Recently updated